Description:LY2090314, with the CAS number 603288-22-8, is a chemical compound that has been investigated primarily for its potential therapeutic applications, particularly in the field of neuroscience. It is classified as a selective antagonist of the 5-HT2A serotonin receptor, which suggests its role in modulating serotonergic signaling pathways. This characteristic makes it a candidate for research into treatments for various psychiatric disorders, including schizophrenia and depression. The compound's structure features a distinct arrangement of functional groups that contribute to its receptor-binding properties. In preclinical studies, LY2090314 has shown promise in reducing certain behavioral symptoms associated with these disorders, indicating its potential efficacy. However, as with many investigational compounds, further studies are necessary to fully understand its pharmacokinetics, safety profile, and therapeutic potential. Overall, LY2090314 represents a significant area of interest in drug development aimed at addressing complex neuropsychiatric conditions.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
